Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SUPN
#1842
Supernus Pharmaceuticals, Inc. - Common Stock
44.1
9
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.54%
Monthly Change
-6.81%
6 month change
-18.15%
Year Change
-18.17%
Previous Close
44.8
8
Open
44.1
9
Low
44.1
9
High
44.1
9
Volume
46
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
SUPN
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q2 FY2024
2024.06.17
SUPERNUS PHARMACEUTICALS, INC. current report, Q2 FY2024
8-K
1
2
3
4
5
6
News
Is the Options Market Predicting a Spike in Supernus Pharmaceuticals Stock?
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
New Strong Buy Stocks for August 7th
Best Value Stocks to Buy for August 7th
INDV to Merge With Supernus, Beats on Q2 Earnings, Raises '26 Outlook
Stocks Settle Sharply Higher as Middle East Tensions Ease
Supernus Pharmaceuticals, Inc. (SUPN) M&A Call Transcript
Supernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal
Stocks Rally on Easing Geopolitical Risks and US Economic Strength